-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QCbIgDwoooOCXVBInXSkCaRS2NSAr7CZYfBVf/UgzON5Evr6jjVVQX44Yz33kUX6 5PJqJsBKQz0Xe1Qc9sbWoA== 0001140361-02-000262.txt : 20020515 0001140361-02-000262.hdr.sgml : 20020515 20020515115545 ACCESSION NUMBER: 0001140361-02-000262 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20011231 FILED AS OF DATE: 20020515 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 02649479 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 COMPANY DATA: COMPANY CONFORMED NAME: TERRA LISTED LTD CENTRAL INDEX KEY: 0001078474 OWNER FILING VALUES: FORM TYPE: 5 BUSINESS ADDRESS: STREET 1: 2/3 RUE DU PRE CITY: ST PETER PORT GUERNS BUSINESS PHONE: 4113871901 MAIL ADDRESS: STREET 1: 2/3 RUE DU PRE CITY: ST PETER PORT GUERNS FORMER COMPANY: FORMER CONFORMED NAME: TERRA HEALTHY LIVING LTD DATE OF NAME CHANGE: 19990205 5 1 doc1.htm Form 5
Form 5
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

ANNUAL STATEMENT OF CHANGES
BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0362
Expires: January 31, 2005
[ ] Check box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See instructions 1(b).
Estimated average burden
hours per response. . . 1.0
[ ] Form 3 Holdings Reported
[X] Form 4 Transactions Reported
1. Name and Address of Reporting Person*
Terra Listed LTD
2. Issuer Name and Ticker or Trading Symbol
Amedisys Inc.,   (AMED)

6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
___ Director                    _X_ 10% Owner
___ Officer (give             ___ Other (specify
                  title below)                     below)


(Last)             (First)            (Middle)

2/3 Rue Du Pre
3. I.R.S. Identification Number of Reporting Person, if an entity
(voluntary)

4. Statement for Month/Year
12/2001
(Street)

St. Peter Port, Guernsey Channel Islands GY1 3NS
5. If Amendment, Date of Original (Month/Year)
7. Individual or Joint/Group Filing
(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)             (State)             (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security
(Instr. 3)
2. Transaction Date
(Month/Day/Year)
3. Transaction
Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year
(Instr. 3 and 4)
6. Owner-
ship Form:
Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A)
or
(D)
Price
Common Stock 11/07/2001 C   1,166,667 A   1,414,167 D  
* If the form is filed by more than one reporting person, see instruction 4(b)(v).
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
(Over)
SEC 2270 (3-99)
FORM 5 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
 
1.Title of Derivative Security
(Instr.3)
2. Conversion or
Exercise
Price of
Derivative
Security
3. Transaction
Date
(Month/
Day/
Year)
4. Transaction Code
(Instr. 8)
5. Number of Derivative
Securities
Acquired (A) or Disposed of(D)
(Instr. 3, 4 and 5)
6. Date Exercisable
and Expiration Date
(Month/Day/Year)
7. Title and Amount of
Underlying Securities
(Instr. 3 and 4)
8. Price of
Derivative
Security
(Instr. 5)
9.Number of
Derivative
Securities
Beneficially
Owned at
End of
Year
(Instr. 4)
10. Ownership
Form of
Derivative
Security:
Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of
Indirect
Beneficial
Ownership
(Instr. 4)
Code V (A) (D) Date
Exercisable
Expiration
Date
Title Amount
or
Number
of Shares
Series A Convertible Preferred Stock 1:3.333333 11/07/2001 C     350,000     Common Stock 1,166,667   0 D  
Explanation of Responses:



** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ John A. Ewen
**Signature of Reporting Person
05/15/2002 
Date
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. Page 2
-----END PRIVACY-ENHANCED MESSAGE-----